Article

Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variants

2021-05-27

Abstract excerpt

<h4>Background</h4> Serological tests are beneficial for recognizing the immune response against SARS-CoV-2. To identify protective immunity, optimization of the chemiluminescent reduction neutralizing test (CRNT), using pseudotyped SARS-CoV-2, is critical. Whether commercial antibody tests are comparably accurate is unknown. <h4>Methods</h4> Serum samples collected before variants were locally found were obtained...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d00d71c8-6419-5446-b589-5db1f17efca6
DOI: 10.1101/2021.05.25.21257828

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variantsDOI 10.1101/2021.05.25.21257828Read

The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Semantic proximity Read

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodiesSemantic proximity Read

Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19Semantic proximity Read

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity Read

Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology testsSemantic proximity Read

Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunitySemantic proximity Read

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read

Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workersSemantic proximity Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read

Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in ArgentinaSemantic proximity Read

Changes of Humoral Immunity Response in SARS-CoV-2 Convalescent Patients over 8 monthsSemantic proximity Read